Dr. Anna Korban, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 185 S Orange Ave # Msbf-611, Newark, NJ 07103 Phone: 973-972-5007 Fax: 973-972-0582 |
Dr. Deepa Asokan, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 185 S Orange Ave, Msb Ste E547, Newark, NJ 07103 Phone: 973-972-5006 |
Dr. Lawrence Willis Chinn Sr., MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 150 Bergen St, Newark, NJ 07103 Phone: 856-235-1983 |
Dr. Da Wang, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 185 S Orange Ave Rm E-538, Newark, NJ 07103 Phone: 973-972-0470 |
Anastasios Fotinos, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 111 Central Ave, Newark, NJ 07102 Phone: 973-877-5000 |
Jose R Chan, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 201 Lyons Ave, Newark, NJ 07112 Phone: 201-943-0034 Fax: 201-943-8105 |
Bong H Choi, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 155 Jefferson St, Newark, NJ 07105 Phone: 908-490-0036 Fax: 908-490-0067 |
Corazon C Maurrasse, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 201 Lyons Ave, Newark, NJ 07112 Phone: 201-943-0034 Fax: 201-943-8105 |
Benjamin Rubin, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 185 S Orange Ave, Msb-e538, Newark, NJ 07103 Phone: 973-972-0470 |
Dr. Julian Entrada, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 268 Martin Luther King Jr Blvd, Newark, NJ 07102 Phone: 973-877-5034 Fax: 973-877-5231 |
Owen R. Rahman, M.D. Anesthesiology - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 30 Bergen St, Admc 12 1205, Newark, NJ 07107 Phone: 973-972-0037 Fax: 973-972-9355 |
Dr. Vely Anthony Louis, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 201 Lyons Ave, Newark, NJ 07112 Phone: 973-926-7655 Fax: 973-282-3285 |
Xun Ru, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 201 Lyons Ave, Newark, NJ 07112 Phone: 201-943-0034 Fax: 201-943-8105 |
Barbara Zwolska-demczuk, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 201 Lyons Ave, Newark, NJ 07112 Phone: 201-943-0034 Fax: 201-943-8105 |
Dr. Ripal Patel, M.D. Anesthesiology - Pain Medicine Medicare: Not Enrolled in Medicare Practice Location: 150 Bergen St, Newark, NJ 07103 Phone: 973-945-8811 |
Vincent Capalbo, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 111 Central Ave, Newark, NJ 07102 Phone: 973-877-5000 |
Dennis George Grech, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 150 Bergen St, Newark, NJ 07103 Phone: 856-235-1983 |
Dr. Michael Danila, CRNA Anesthesiology Medicare: Medicare Enrolled Practice Location: 201 Lyons Ave, Newark, NJ 07112 Phone: 800-843-2384 |
Dr. Michael Suleiman Marji, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: St. Michael's Medical Center, 111 Central Avenue, Newark, NJ 07102 Phone: 973-877-5000 |
Prabhakara Amuluru, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 111 Central Ave, Newark, NJ 07102 Phone: 973-877-5000 |
News Archive
For more than 1 million people in the U.S. living with spinal cord injury, the frightening days and weeks following the injury are filled with uncertainty about their potential for recovery and future independence. A new model based on motor scores at admission and early imaging studies may allow clinicians to predict functional outcomes and guide decision-making for therapy and care-giving needs, as described in an article published in Journal of Neurotrauma, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Early findings by researchers at the University of Cincinnati College of Medicine suggest that the use of a second generation cancer drug, carfilzomib, may provide an improved approach for the reduction of antibodies in potential kidney transplant candidates.
ViroPharma Incorporated today announced that it has completed enrollment in its Phase 2 study evaluating subcutaneous delivery of Cinryze™ (C1esterase inhibitor [human]). This multi-center, open-label, multi-dose Phase 2 study is designed to evaluate the safety, pharmacokinetics and pharmacodynamics of subcutaneous versus intravenous administration of Cinryze in adolescent and adult subjects with hereditary angioedema (HAE).
A new initiative aims to accelerate the search for biomarkers - changes in the body that can be used to predict, diagnose or monitor a disease - in Parkinson's disease, in part by improving collaboration among researchers and helping patients get involved in clinical studies.
Trevena, Inc., a clinical stage pharmaceutical company involved in the discovery and development of G-protein coupled receptor biased ligands, announced today initiation of dosing in BLAST-AHF, the Company's randomized, multi-center Phase 2b trial of TRV027 in patients with acute heart failure.
› Verified 6 days ago